CinCor Pharma, Inc.
CINC · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $21,514 | $17,952 | $3,926 |
| G&A Expenses | $20,996 | $3,173 | $1,211 |
| SG&A Expenses | $20,996 | $3,173 | $1,211 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $42,510 | $21,125 | $5,137 |
| Operating Income | -$42,510 | -$21,125 | -$5,137 |
| % Margin | – | – | – |
| Other Income/Exp. Net | -$7,859 | -$1,173 | $102 |
| Pre-Tax Income | -$50,369 | -$22,299 | -$5,035 |
| Tax Expense | -$22 | -$37 | -$102 |
| Net Income | -$50,347 | -$22,262 | -$4,933 |
| % Margin | – | – | – |
| EPS | -1.42 | -0.95 | -0.21 |
| % Growth | -49.5% | -352.4% | – |
| EPS Diluted | -1.42 | -0.95 | -0.21 |
| Weighted Avg Shares Out | 35,419 | 23,494 | 23,494 |
| Weighted Avg Shares Out Dil | 35,419 | 23,494 | 23,494 |
| Supplemental Information | – | – | – |
| Interest Income | $22 | $37 | $102 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $7,880 | $1,210 | $172 |
| EBITDA | -$34,630 | -$19,916 | -$5,137 |
| % Margin | – | – | – |